Jonathan Yong
Stock Analyst at UBS
(2.66)
# 2,176
Out of 5,072 analysts
96
Total ratings
61.11%
Success rate
11.48%
Average return
Main Sectors:
Stocks Rated by Jonathan Yong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| OSCR Oscar Health | Maintains: Sell | $11 → $12 | $18.16 | -33.92% | 9 | Nov 7, 2025 | |
| EHTH eHealth | Maintains: Neutral | $7 → $5 | $4.07 | +22.85% | 6 | Aug 7, 2025 | |
| CLOV Clover Health Investments | Maintains: Neutral | $4.5 → $3 | $2.45 | +22.45% | 4 | Aug 6, 2025 | |
| EHAB Enhabit | Maintains: Neutral | $15 → $12 | $9.03 | +32.89% | 3 | Aug 11, 2023 | |
| GDRX GoodRx Holdings | Maintains: Neutral | $7 → $8 | $2.83 | +182.69% | 4 | Aug 10, 2023 | |
| CCRN Cross Country Healthcare | Maintains: Neutral | $27 → $26 | $10.67 | +143.67% | 2 | Aug 8, 2023 | |
| HIMS Hims & Hers Health | Reiterates: Outperform | $14 | $38.40 | -63.54% | 3 | Aug 8, 2023 | |
| HSIC Henry Schein | Reiterates: Outperform | $96 | $75.26 | +27.56% | 3 | Aug 8, 2023 | |
| SEM Select Medical Holdings | Maintains: Neutral | $29 → $32 | $15.41 | +107.66% | 3 | Aug 7, 2023 | |
| AMN AMN Healthcare Services | Maintains: Outperform | $115 → $105 | $17.22 | +509.76% | 4 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $76 → $80 | $116.25 | -31.18% | 3 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $247 → $231 | $268.27 | -13.89% | 6 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $27 | $7.45 | +262.42% | 5 | Jul 26, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $90 → $100 | $213.14 | -53.08% | 2 | Jun 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $430 → $450 | $883.71 | -49.08% | 3 | May 12, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $15 → $12 | $2.81 | +327.05% | 3 | May 5, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $80 → $70 | $4.11 | +1,603.16% | 2 | May 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $17 | $18.95 | -10.29% | 2 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $347 → $350 | $148.33 | +135.96% | 3 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $93 → $95 | $17.16 | +453.61% | 1 | Apr 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underperform | $7 → $8.5 | $2.93 | +190.10% | 2 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $41 | $24.46 | +67.62% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $20 → $17 | $2.75 | +518.18% | 2 | Mar 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3.3 → $8.5 | $3.45 | +146.38% | 2 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $85 | $79.03 | +7.55% | 1 | Feb 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $143 → $146 | $189.69 | -23.03% | 1 | Jan 25, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $104 → $106 | $39.46 | +168.63% | 3 | Dec 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $129 → $157 | $244.18 | -35.70% | 1 | Nov 25, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $329 → $368 | $278.35 | +32.21% | 2 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $548 → $635 | $245.99 | +158.14% | 2 | Nov 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $113 → $117 | $79.86 | +46.51% | 2 | Aug 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $31 → $30 | $24.45 | +22.70% | 1 | May 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $267 → $298 | $514.76 | -42.11% | 1 | Oct 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $88 → $95 | $217.42 | -56.31% | 2 | Oct 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $462 → $495 | $329.71 | +50.13% | 1 | Oct 15, 2021 |
Oscar Health
Nov 7, 2025
Maintains: Sell
Price Target: $11 → $12
Current: $18.16
Upside: -33.92%
eHealth
Aug 7, 2025
Maintains: Neutral
Price Target: $7 → $5
Current: $4.07
Upside: +22.85%
Clover Health Investments
Aug 6, 2025
Maintains: Neutral
Price Target: $4.5 → $3
Current: $2.45
Upside: +22.45%
Enhabit
Aug 11, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $9.03
Upside: +32.89%
GoodRx Holdings
Aug 10, 2023
Maintains: Neutral
Price Target: $7 → $8
Current: $2.83
Upside: +182.69%
Cross Country Healthcare
Aug 8, 2023
Maintains: Neutral
Price Target: $27 → $26
Current: $10.67
Upside: +143.67%
Hims & Hers Health
Aug 8, 2023
Reiterates: Outperform
Price Target: $14
Current: $38.40
Upside: -63.54%
Henry Schein
Aug 8, 2023
Reiterates: Outperform
Price Target: $96
Current: $75.26
Upside: +27.56%
Select Medical Holdings
Aug 7, 2023
Maintains: Neutral
Price Target: $29 → $32
Current: $15.41
Upside: +107.66%
AMN Healthcare Services
Aug 4, 2023
Maintains: Outperform
Price Target: $115 → $105
Current: $17.22
Upside: +509.76%
Aug 4, 2023
Maintains: Outperform
Price Target: $76 → $80
Current: $116.25
Upside: -31.18%
Aug 2, 2023
Maintains: Outperform
Price Target: $247 → $231
Current: $268.27
Upside: -13.89%
Jul 26, 2023
Reiterates: Neutral
Price Target: $27
Current: $7.45
Upside: +262.42%
Jun 12, 2023
Maintains: Neutral
Price Target: $90 → $100
Current: $213.14
Upside: -53.08%
May 12, 2023
Maintains: Outperform
Price Target: $430 → $450
Current: $883.71
Upside: -49.08%
May 5, 2023
Maintains: Neutral
Price Target: $15 → $12
Current: $2.81
Upside: +327.05%
May 4, 2023
Maintains: Neutral
Price Target: $80 → $70
Current: $4.11
Upside: +1,603.16%
Apr 28, 2023
Maintains: Neutral
Price Target: $14 → $17
Current: $18.95
Upside: -10.29%
Apr 28, 2023
Maintains: Outperform
Price Target: $347 → $350
Current: $148.33
Upside: +135.96%
Apr 28, 2023
Maintains: Outperform
Price Target: $93 → $95
Current: $17.16
Upside: +453.61%
Apr 4, 2023
Maintains: Underperform
Price Target: $7 → $8.5
Current: $2.93
Upside: +190.10%
Mar 7, 2023
Reiterates: Outperform
Price Target: $41
Current: $24.46
Upside: +67.62%
Mar 7, 2023
Maintains: Neutral
Price Target: $20 → $17
Current: $2.75
Upside: +518.18%
Feb 17, 2023
Maintains: Neutral
Price Target: $3.3 → $8.5
Current: $3.45
Upside: +146.38%
Feb 16, 2023
Reiterates: Outperform
Price Target: $85
Current: $79.03
Upside: +7.55%
Jan 25, 2023
Maintains: Neutral
Price Target: $143 → $146
Current: $189.69
Upside: -23.03%
Dec 19, 2022
Maintains: Outperform
Price Target: $104 → $106
Current: $39.46
Upside: +168.63%
Nov 25, 2022
Maintains: Outperform
Price Target: $129 → $157
Current: $244.18
Upside: -35.70%
Nov 7, 2022
Maintains: Outperform
Price Target: $329 → $368
Current: $278.35
Upside: +32.21%
Nov 3, 2022
Maintains: Outperform
Price Target: $548 → $635
Current: $245.99
Upside: +158.14%
Aug 8, 2022
Maintains: Outperform
Price Target: $113 → $117
Current: $79.86
Upside: +46.51%
May 3, 2022
Maintains: Outperform
Price Target: $31 → $30
Current: $24.45
Upside: +22.70%
Oct 25, 2021
Maintains: Outperform
Price Target: $267 → $298
Current: $514.76
Upside: -42.11%
Oct 22, 2021
Maintains: Outperform
Price Target: $88 → $95
Current: $217.42
Upside: -56.31%
Oct 15, 2021
Maintains: Outperform
Price Target: $462 → $495
Current: $329.71
Upside: +50.13%